You are here: » News » Newsdetails: Avastin as effective as Eylea for treating...


Avastin as effective as Eylea for treating central retinal vein occlusion

July 08, 2017

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health.

After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.